JPMorgan Chase & Co’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-661,789
| Closed | -$7.38M | – | 4845 |
|
|
2017
Q3 | $7.38M | Buy |
661,789
+15,356
| +2% | +$171K | ﹤0.01% | 1944 |
|
|
2017
Q2 | $7.11M | Sell |
646,433
-38,229
| -6% | -$421K | ﹤0.01% | 1926 |
|
|
2017
Q1 | $6.71M | Buy |
684,662
+213,842
| +45% | +$2.1M | ﹤0.01% | 1925 |
|
|
2016
Q4 | $5.09M | Buy |
470,820
+466,260
| +10,225% | +$5.04M | ﹤0.01% | 2134 |
|
|
2016
Q3 | $47K | Buy |
4,560
+2,984
| +189% | +$30.8K | ﹤0.01% | 3612 |
|
|
2016
Q2 | $20K | Buy |
1,576
+12
| +0.8% | +$152 | ﹤0.01% | 3718 |
|
|
2016
Q1 | $17K | Buy |
1,564
+774
| +98% | +$8.41K | ﹤0.01% | 3643 |
|
|
2015
Q4 | $8K | Buy |
+790
| New | +$8K | ﹤0.01% | 3671 |
|
|
2014
Q1 | – | Sell |
-437,723
| Closed | -$2.21M | – | 3702 |
|
|
2013
Q4 | $2.21M | Sell |
437,723
-38,083
| -8% | -$192K | ﹤0.01% | 2481 |
|
|
2013
Q3 | $2.41M | Sell |
475,806
-32,993
| -6% | -$167K | ﹤0.01% | 2470 |
|
|
2013
Q2 | $2.52M | Buy |
+508,799
| New | +$2.52M | ﹤0.01% | 2392 |
|